Premium
National and subnational mortality of urological cancers in Iran, 1990–2015
Author(s) -
Pishgar Farhad,
Amini Erfan,
Gohari Kimiya,
Aminorroaya Arya,
Sheidaei Ali,
Rostamabadi Yasna,
Ebrahimi Hooman,
Yoosefi Moein,
Naderimagham Shohreh,
Rezaei Nazila,
Modirian Mitra,
Namazi Shabestari Alireza,
Kompani Farzad,
Farzadfar Farshad
Publication year - 2019
Publication title -
asia‐pacific journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 29
eISSN - 1743-7563
pISSN - 1743-7555
DOI - 10.1111/ajco.13074
Subject(s) - medicine , mortality rate , demography , bladder cancer , cause of death , cancer , prostate cancer , disease , sociology
Purpose To study trends of urological cancers mortalities in Iran between 1990 and 2015 as a part of a larger project named national and subnational burden of diseases, injuries, and risk factors. Methods The primary dataset of this project comprises data of national death registration system. Cause‐specific mortality fraction for each age, sex, province, and year group was calculated using a two‐stage mixed effects and spatiotemporal models, and then these fractions were applied to all‐cause mortality rates, obtained from a parallel study to estimate mortality rates attributable to each cause. Results In 2015, urological cancers constituted 8% of cancer‐related deaths in Iran, and number of deaths due to prostate, bladder, testicular, and kidney and other urinary organs cancers were estimated as 2,128 (1,565–2,891), 297 (230–385), 301 (144–639), and 195 (143–267), respectively. Our estimates show that age‐standardized death rates (ASDRs) of these cancers reached 6.8 (5–9.23), 0.47 (0.37–0.61), 0.96 (0.46–2.04), and 0.24 (0.18–0.33) deaths per 100,000 individuals in 2015, a reduction in the three latter cancers, from 4.09 (2.92–5.76), 13.04 (10.04–16.95), 1.23 (0.46–3.34), and 1.76 (1.28–2.42) deaths per 100,000 individuals in 1990, respectively. Conclusions In conclusion, despite disparities among different provinces, overall mortality rate of urological cancers decreased significantly since 1990s in Iran.